Literature DB >> 15182215

The National Service Framework for Older People: England's approach to ending age discrimination in services and therapeutics.

Peter Crome1, Indira Natarajan.   

Abstract

In 1997, the new Labour Government in the UK embarked on an ambitious programme of reform. One of the key changes has been the publication of a series of National Service Frameworks. The National Service Framework for Older People (NSFOP) sets out a 10-year programme that has as its principal standard rooting out age discrimination. Together with its companion documents, a series of robust milestones and standards are set out that have to be met. Although generally welcomed by the profession, the NSFOP has been criticised by some because it mandates the initiation of new 'intermediate care' services that may be seen as denying older people the opportunity for admission to mainstream hospital care. Monitoring tools covering both procedures and prescribing have been developed. The government-produced frameworks mirror guidelines produced by the profession and include a number of prescribing recommendations, e.g. the use of antihypertensives and aspirin (acetylsalicylic acid) in the prevention of stroke, and the use of calcium, vitamin D and bisphosphonates in the treatment of osteoporosis. In tackling age discrimination, both direct and indirect barriers to effective prescribing need to be considered. The evidence base on the effectiveness of medication in older people is more limited due to the previous systematic exclusion of older people from clinical trials. The consequent lack of evidence of efficacy, coupled with perhaps a natural reluctance to prescribe potentially toxic medication, may lead to underprescribing. Other indirect causes of age discrimination may include difficulties for older people attending hospitals for drug monitoring, and the difficulties of translating the results of trials into meaningful endpoints that older patients can understand and thus make valid decisions about whether they wish to take the particular drug or not. At the same time as the NSFOP argues against age discrimination, other government policies may operate in a contradictory manner. Examples include the trend to make drugs available over the counter in pharmacies and for which the patient has to pay rather than receive them free, the restriction of some prescription-only drugs from the health service, and the need for referral to specialist services for some drugs, e.g. sildefanil, which older people may be reluctant to access. Successfully combating age discrimination is likely to require a regulatory framework, continued monitoring, tackling indirect forms of discrimination, as well as embedding antidiscrimination policies in all facets of health education. Copyright 2004 Adis Data Information BV

Entities:  

Mesh:

Year:  2004        PMID: 15182215     DOI: 10.2165/00002512-200421080-00002

Source DB:  PubMed          Journal:  Drugs Aging        ISSN: 1170-229X            Impact factor:   3.923


  29 in total

1.  The influence of age on policies for admission and thrombolysis in coronary care units in the United Kingdom.

Authors:  N J Dudley; E Burns
Journal:  Age Ageing       Date:  1992-03       Impact factor: 10.668

2.  The rationing debate. Rationing health care by age.

Authors:  A Williams; J G Evans
Journal:  BMJ       Date:  1997-03-15

3.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

4.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

5.  Age- and sex-related bias in the management of heart disease in a district general hospital.

Authors:  Nigel J Dudley; Ann Bowling; Matthew Bond; Dorothy McKee; Marie McClay Scott; Adrian Banning; Andrew T Elder; A Tony Martin; Iva Blackman
Journal:  Age Ageing       Date:  2002-01       Impact factor: 10.668

6.  Elderly and younger patients selected to undergo coronary angiography.

Authors:  A T Elder; T R Shaw; C M Turnbull; I R Starkey
Journal:  BMJ       Date:  1991-10-19

Review 7.  Lessons from the Stroke Prevention in Atrial Fibrillation trials.

Authors:  Robert G Hart; Jonathan L Halperin; Lesly A Pearce; David C Anderson; Richard A Kronmal; Ruth McBride; Elaine Nasco; David G Sherman; Robert L Talbert; John R Marler
Journal:  Ann Intern Med       Date:  2003-05-20       Impact factor: 25.391

8.  Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study.

Authors:  Tom Fahey; Alan A Montgomery; James Barnes; Jo Protheroe
Journal:  BMJ       Date:  2003-03-15

9.  Effect of nitrazepam in chronic obstructive bronchitis.

Authors:  J Gaddie; J S Legge; K N Palmer; J C Petrie; R A Wood
Journal:  Br Med J       Date:  1972-06-17

10.  Rationing treatment on the NHS--still a political issue.

Authors:  Elias Mossialos; Martin McKee
Journal:  J R Soc Med       Date:  2003-08       Impact factor: 18.000

View more
  1 in total

Review 1.  Chronic hepatitis C in the aged: much ado about nothing or nothing to do?

Authors:  Stephen Malnick; Yaakov Maor; Ehud Melzer; Sari Tal
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.